Document is current
Any future updates will be listed below
-
Authors
Zhang, Haixin
Tahami Monfared, Amir Abbas https://orcid.org/0000-0003-4003-3192
Zhang, Quanwu
Honig, Lawrence S.
-
Funding
Funding for this research was provided by:
Eisai Incorporated
- License Information
-
More Information
Article History
Received: 31 October 2024
Accepted: 5 December 2024
First Online: 19 December 2024
Declarations
:
: Haixin Zhang and Quanwu Zhang are employees of Eisai, Inc. (Nutley, NJ, USA). Amir Abbas Tahami Monfared is an employee of Eisai Inc. (Nutley, NJ, USA) and holds the position of Adjunct Professor of Epidemiology and Biostatistics at McGill University. He also serves as an Associate Editor for the Journal of Alzheimer's Disease but does not receive honoraria for this role. Lawrence Honig has received funding for consultation from Biogen, Eisai, Genentech/Roche, Medscape, and Prevail/Lilly. Additionally, he has received institutional research funding from Abbvie, Acumen, Alector, AstraZeneca, Biogen, Bristol-Myer Squibb, Cognition, EIP, Eisai, Genentech/Roche, Janssen/Johnson & Johnson, Eli Lilly, Merck, Transposon, UCB, and Vaccinex.
: This analysis conformed to CMS privacy requirements; an approval for the overarching database research protocol was obtained through a central IRB. The entire CMS beneficiary population over the selected time period was analyzed to assure diversity, equity, and inclusion. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Patient data were deidentified, and due to the study's retrospective design, obtaining formal patient consent was not required. This study does not involve any new research with human participants or animals conducted by the authors.
